Río de Janeiro, Brasil, 12 de marzo de 2018 (OPS/OMS)– La directora de la Organización Panamericana de la Salud (OPS), Carissa F. Etienne, presentó un panorama sobre la medicina tradicional en la región de las Américas, durante la apertura del 1º Congreso Internacional de Prácticas Integrativas y Salud Pública, que se desarrolla hasta el jueves en Río de Janeiro.

“Acelerar los esfuerzos de los países para lograr la salud universal en 2030 – como se comprometió el mundo en la nueva Agenda de Desarrollo Sostenible – requiere escuchar las voces de las personas, prestar atención a las múltiples formas de entender el mundo en que vivimos, las múltiples culturas y tradiciones, incluida su medicina tradicional”, afirmó Etienne.

(…)

For more information go to http://www.paho.org/hq/index.php?option=com_content&view=article&id=14186%3Adirectora-de-la-ops-presenta-en-brasil-panorama-de-la-medicina-tradicional-en-las-americas&catid=1443%3Aweb-bulletins&Itemid=135&lang=en

The WHO Regulatory Standards for Vaccines and Biologicals unit opened a public consultation for regulators, manufacturers and other experts. The following document has been posted on the WHO biologicals web site http://www.who.int/biologicals/en/ for public comments:

1. Guidelines for the safe production and quality control of poliomyelitis vaccine

http://www.who.int/biologicals/WHO_Safe_production_of_Polio_1st_PC_6_March_2018.pdf?ua=1

2. Comment Form http://www.who.int/entity/biologicals/Comment_Form_POLIO_6_March_2018.doc?ua=1

DEADLINE for submission of comments: 04 April 2018

Save the date! Our 6th ISoP–UMC pharmacovigilance course takes place in Guayaquil, Ecuador in September, 24 – 26, 2018. More information will be made available and the registration will open soon.

If you have any questions please contact administration@isoponline.org.

Source: https://www.facebook.com/events/373367596471077/

[Original in Portuguese]

The event, which will deal with Clinical Assessment of Medical Devices, will take place at the Agency’s headquarters on March 27th.

On March 27, Anvisa will host the workshop on Clinical Evaluation of Medical Devices. The event, which will begin at 9:00 am in the auditorium of the Agency, counts on the partnership of the Brazilian Association of the Industry of Articles and Medical, Dental, Hospital and Laboratories (Abimo), Brazilian Association of the High Technology Product Industry for Health (Abimed) and the Brazilian Association of Importers and Distributors of Health Products (Abraidi).
The workshop aims to disseminate knowledge and improve processes and practices through the sharing of national and international experiences and the identification of difficulties and challenges related to the theme.

For more information go to http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/4085408 

April 30 – May 1, 2018

The Global Cancer Clinical Research, Drug Development and Therapeutic Accessibility Workshop is a collaborative effort between the Duke University Center for Applied Therapeutics and the National Cancer Institute’s Center for Global Health.

The availability of new cancer treatments varies widely around the world. This workshop will focus on the clinical testing and development, regulatory approval, and access to/reimbursement for anticancer drug activity that occurs internationally. It will deal with the complex issues specific to international oncology drug development, focusing on molecular subtypes of cancer, rare cancers and pediatric cancers.

The Workshop aims to develop research networks to facilitate collaboration and increase efforts to reduce the global burden of cancer.

For more information go to https://www.globalcancerdrugdevelopment.org/

[Original text in Spanish]

President Danilo Medina received today the visit of the director of the Pan American Health Organization (PAHO), Carissa Etienne, in which they discussed the progress and challenges of the health sector in the Dominican Republic.

Along with Etienne, was Alma Morales Salinas who, on behalf of the director of PAHO, explained the interest of that organization in supporting the public health system of the country, making available technical cooperation to address noncommunicable diseases.

He also said that PAHO will support the Dominican Republic in what it requires for the development of the health city within the framework of strengthening the integrated health service networks.

The meeting was framed in the meeting of managers of the PAHO sub-region, as well as the subregion of Central America, Cuba, Mexico and the Dominican Republic and heads of departments of the regional headquarters of that organization.

For more information go to: https://presidencia.gob.do/noticias/salud-grandes-avances-y-retos-ops-apoyara-sistema-de-salud-publica-y-9-1-1

16 February 2018 | Geneva – WHO is announcing today a new high-level commission, comprised of heads of state and ministers, leaders in health and development and entrepreneurs. The group will propose bold and innovative solutions to accelerate prevention and control of the leading killers on the planet – noncommunicable diseases (NCDs) like heart and lung disease, cancers, and diabetes.

The WHO Independent Global High-level Commission on NCDs is co-chaired by President Tabaré Vázquez of Uruguay; President Maithripala Sirisena of Sri Lanka; President Sauli Niinistö of Finland; Veronika Skvortsova, Minister of Healthcare of the Russian Federation; and Sania Nishtar, former Federal Minister of Pakistan.

(…)

The new Commission was established by WHO Director-General Dr Tedros Adhanom Ghebreyesus and runs until October 2019. It will provide actionable recommendations to contribute to the Third United Nations General Assembly High-level Meeting on NCDs scheduled for the second half of 2018. This will include the submission of its first report to Dr Tedros in early June.

(…)

For more information go to http://www.who.int/mediacentre/news/releases/2018/world-leaders-ncds/en/

As part of the strategy to strengthen links at a global level, the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) participated in the work of India Pharma 2018, where it presented the regulatory advances reported by Mexico to expedite the population’s access to medicines and supplies for quality, safety and efficacy.

For more information go to https://www.gob.mx/cofepris/articulos/fortalece-la-cofepris-vinculos-internacionales-147624?idiom=es

Science at the Service of Public Health: Rafael Pérez Cristiá MD PhD Center for State Control of Medicines and Medical Devices.

(…)

Cuba’s nascent biotechnology sector began making scientific breakthroughs in the 1980s, including the isolation of human leukocyte interferon alpha (1981) and the development of the world’s first safe, effective meningitis BC vaccine (1989). With positive results in hand and a growing R&D pipeline, the island nation established a national regulatory authority (NRA) to implement and oversee best practices for all pharmaceuticals and medical devices, domestically produced and imported, used in the country’s universal health system. Founded in 1989, Cuba’s Center for State Control of Medicines and Medical Devices (CECMED) is the entity charged with regulating all phases of scientific innovation for health, from clinical trial design to postmarketing surveillance.

(…)

For more information go to: http://www.cecmed.cu/content/entrevista-de-medicc-review-director-del-cecmed-science-service-public-health-rafael-perez